# Bioventus Inc.: Form DEF 14A, filed Apr 26, 2024

- Company: [Bioventus Inc.](/companies/bvs.md) (CIK 1665988)
- Form: DEF 14A
- Filed: 2024-04-26
- Accepted by EDGAR: Apr 26, 2024, 07:38 ET
- Period: 2024-06-11
- Accession: 0001628280-24-018431
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1665988/000162828024018431/proxy-2024def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1665988/000162828024018431/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1665988/000162828024018431/proxy-2024def14a.htm

Filed Apr 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-018431. Last ingested by Listed: Nov 2, 2026, 17:44 ET. No prices; not investment advice.